Glenview State Bank Trust Department’s GSK GSK Stock Holding History

Glenview State Bank Trust Department’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$308K	Sell	6,200 -240	-4%	-$11.5K	0.09%	97
2021 Q1	$287K	Hold	6,440	–	–	0.09%	96
2020 Q4	$296K	Hold	6,440	–	–	0.1%	89
2020 Q3	$303K	Sell	6,440 -175	-3%	-$8.77K	0.12%	84
2020 Q2	$338K	Buy	6,615 +175	+3%	+$8.98K	0.14%	78
2020 Q1	$305K	Hold	6,440	–	–	0.15%	78
2019 Q4	$378K	Sell	6,440 -160	-2%	-$8.9K	0.15%	80
2019 Q3	$352K	Hold	6,600	–	–	0.14%	84
2019 Q2	$330K	Hold	6,600	–	–	0.14%	85
2019 Q1	$345K	Hold	6,600	–	–	0.15%	82
2018 Q4	$315K	Hold	6,600	–	–	0.15%	80
2018 Q3	$332K	Hold	6,600	–	–	0.14%	79
2018 Q2	$332K	Hold	6,600	–	–	0.15%	79
2018 Q1	$323K	Buy	6,600 +400	+6%	+$18.6K	0.15%	79
2017 Q4	$274K	Hold	6,200	–	–	0.13%	86
2017 Q3	$315K	Sell	6,200 -240	-4%	-$12.2K	0.15%	80
2017 Q2	$347K	Hold	6,440	–	–	0.18%	74
2017 Q1	$339K	Buy	6,440 +1,480	+30%	+$75.1K	0.18%	72
2016 Q4	$239K	Hold	4,960	–	–	0.13%	80
2016 Q3	$267K	Sell	4,960 -160	-3%	-$8.77K	0.15%	78
2016 Q2	$277K	Hold	5,120	–	–	0.16%	76
2016 Q1	$260K	Hold	5,120	–	–	0.16%	78
2015 Q4	$258K	Buy	+5,120	New	+$261K	0.16%	74
2015 Q2	–	Sell	-3,760	Closed	-$217K	–	87
2015 Q1	$217K	Hold	3,760	–	–	0.13%	81
2014 Q4	$201K	Sell	3,760 -910	-19%	-$50.9K	0.12%	82
2014 Q3	$268K	Sell	4,670 -800	-15%	-$49K	0.16%	72
2014 Q2	$365K	Sell	5,470 -1,040	-16%	-$70.4K	0.22%	59
2014 Q1	$435K	Hold	6,510	–	–	0.27%	56
2013 Q4	$434K	Buy	+6,510	New	+$422K	0.27%	55

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Glenview State Bank Trust Department's GSK Position: Q2 2021 in Review

Glenview State Bank Trust Department reduced its GSK (GSK) stake by 3.7% in Q2 2021, selling an estimated $11.5K and leaving 6,200 shares worth $308K. The position accounts for 0.09% of the portfolio, ranked #97.

Glenview State Bank Trust Department first reported a position in GSK in Q4 2013 and has held it in 29 quarters since. The position peaked at $435K in Q1 2014. 799 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

Glenview State Bank Trust Department held 6,200 shares of GSK worth $308K as of Q2 2021.
Glenview State Bank Trust Department sold 240 GSK shares in Q2 2021, an estimated $11.5K.
GSK made up 0.09% of Glenview State Bank Trust Department's portfolio in Q2 2021, its #97 holding.
Glenview State Bank Trust Department first reported a position in GSK in Q4 2013 and has held it in 29 quarters since.
Glenview State Bank Trust Department's GSK position peaked at $435K in Q1 2014.
799 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Glenview State Bank Trust Department's 13F filing for Q2 2021, filed 28 Jul 2021.